MediWound receives $15M investment from Molnlycke Health Care

MediWound announced today an investment of $15M from Molnlycke Health Care, a MedTech company specialising in solutions for wound care and surgical procedures, through a definitive share purchase agreement in a private investment in public equity. Molnlycke and MediWound have also entered into a collaboration agreement. Under this agreement, Molnlycke is granted specific rights, including having a representative attend meetings of MediWound’s R&D Committee and will also be able to participate in potential strategic partnership discussions and M&A processes under certain circumstances.